A vegetarian diet improves hepatic steatosis in MASLD patients through weight loss: a randomized controlled trial in China (original) (raw)
* Corresponding authors
a School of Public Health, Shanghai Jiao Tong University School of Medicine, Shanghai, China
E-mail: srachel@126.com
b Department of Clinical Nutrition, College of Health Science and Technology, Shanghai Jiao Tong University School of Medicine, Shanghai, China
c Department of Clinical Nutrition, Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China
d Department of Nutrition and Dietetics, Brooks College of Health, University of North Florida, Jacksonville, FL, USA
e Shanghai Key Laboratory of Pediatric Gastroenterology and Nutrition, Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China
Abstract
Objective: The therapeutic potential of vegetarian diets in metabolic dysfunction-associated steatotic liver disease (MASLD) remains understudied in Asian populations. This randomized controlled trial aimed to evaluate the effects of a culturally adapted 6-month lacto-ovo-vegetarian diet (LOV-D) on hepatic steatosis and cardiometabolic risk factors through weight loss. Methods: In this randomized trial, 220 Chinese adults with MASLD were assigned to LOV-D (n = 110) or an omnivore diet (n = 110) for 6 months. Both groups received dietitian-supervised meal plans. Primary outcomes included weight, body fat, and visceral fat area (VFA) changes via bioelectrical impedance. Secondary outcomes encompassed hepatic steatosis (controlled attenuation parameter [CAP], ultrasonography) and cardiometabolic markers. Results: Among 186 completers (84.5% retention; mean age 40.0, BMI 28.4 kg m−2), the LOV-D group achieved greater reductions in weight (−1.40 kg [95% CI: −2.72 to −0.73], p = 0.033), fat mass (−11.94% vs −8.27%, p = 0.048), and VFA (−9.76% vs. −4.65%, p = 0.012) versus controls. LOV-D participants exhibited higher rates of composite endpoints (≥5% weight loss plus steatosis improvement): 33.3% vs. 16.1% by ultrasonography (p = 0.007) and 37.6% vs. 21.5% by CAP (p = 0.016). Significant improvements in Framingham risk scores, LDL cholesterol, and blood pressure occurred exclusively in the LOV-D group (all p < 0.05). Subgroup analyses revealed amplified benefits in females. Conclusions: A 6-month LOV-D intervention significantly attenuated MASLD severity through concurrent weight and visceral fat reduction, particularly in females. These findings support LOV-D as a culturally tailored, sex-responsive dietary strategy for MASLD management in Chinese populations.
You have access to this article
Please wait while we load your content... Something went wrong. Try again?
Supplementary files
Article information
DOI
https://doi.org/10.1039/D5FO02970H
Article type
Paper
Submitted
13 Jul 2025
Accepted
31 Aug 2025
First published
08 Sep 2025
Download Citation
Food Funct., 2025,16, 7678-7689
Permissions
A vegetarian diet improves hepatic steatosis in MASLD patients through weight loss: a randomized controlled trial in China
X. Mao, K. Xu, C. Wang, X. Lu, X. Yao, F. Song, Z. Yu, L. Qian, Y. Feng and X. Shen,Food Funct., 2025, 16, 7678DOI: 10.1039/D5FO02970H
To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.
If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.
If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.
Read more about how to correctly acknowledge RSC content.